Literature DB >> 24636456

The other side of the histamine H3 receptor.

Bart A Ellenbroek1, Bibinaz Ghiabi2.   

Abstract

Although histamine H3 receptors are predominantly known as presynaptic receptors, regulating the release of neurotransmitters such as dopamine, acetylcholine, and histamine, in the striatal complex the vast majority of these receptors are actually located on the other side, in other words postsynaptically. Given their strategic location, they can crucially affect signaling throughout the basal ganglia. We describe the anatomy and function of H3 receptors within the basal ganglia with a specific focus on their colocalization with dopamine D1 and D2 receptors. Because the basal ganglia are centrally involved in several major neurological and psychiatric disorders, we also discuss the therapeutic potential of drugs targeting H3 receptors in the treatment of Parkinson disease (PD), schizophrenia, and addiction.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  D1 receptor; D2 receptor; H3 receptor; Parkinson disease; addiction; basal ganglia; direct pathway; dopamine; histamine; indirect pathway; schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 24636456     DOI: 10.1016/j.tins.2014.02.007

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  17 in total

1.  Histamine H1 receptor occupancy by the new-generation antipsychotics olanzapine and quetiapine: a positron emission tomography study in healthy volunteers.

Authors:  Hirotoshi Sato; Chihiro Ito; Kotaro Hiraoka; Manabu Tashiro; Katsuhiko Shibuya; Yoshihito Funaki; Takeo Yoshikawa; Ren Iwata; Hiroo Matsuoka; Kazuhiko Yanai
Journal:  Psychopharmacology (Berl)       Date:  2015-07-07       Impact factor: 4.530

2.  Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors.

Authors:  Qian-Xing Zhuang; Han-Ting Xu; Xu-Juan Lu; Bin Li; Wing-Ho Yung; Jian-Jun Wang; Jing-Ning Zhu
Journal:  Mol Neurobiol       Date:  2018-03-01       Impact factor: 5.590

Review 3.  Pharmacological Characterization of Human Histamine Receptors and Histamine Receptor Mutants in the Sf9 Cell Expression System.

Authors:  Erich H Schneider; Roland Seifert
Journal:  Handb Exp Pharmacol       Date:  2017

4.  Histamine H3 Receptor Activation Modulates Glutamate Release in the Corticostriatal Synapse by Acting at CaV2.1 (P/Q-Type) Calcium Channels and GIRK (KIR3) Potassium Channels.

Authors:  Héctor Vázquez-Vázquez; Carolina Gonzalez-Sandoval; Ana V Vega; José-Antonio Arias-Montaño; Jaime Barral
Journal:  Cell Mol Neurobiol       Date:  2020-10-17       Impact factor: 5.046

Review 5.  Histamine: A Key Neuromodulator of Memory Consolidation and Retrieval.

Authors:  Hiroshi Nomura; Rintaro Shimizume; Yuji Ikegaya
Journal:  Curr Top Behav Neurosci       Date:  2022

Review 6.  Targeting Histamine and Histamine Receptors for the Precise Regulation of Feeding.

Authors:  Yanrong Zheng; Zhong Chen
Journal:  Curr Top Behav Neurosci       Date:  2022

7.  Functional histamine H3 and adenosine A2A receptor heteromers in recombinant cells and rat striatum.

Authors:  Ricardo Márquez-Gómez; Meridith T Robins; Citlaly Gutiérrez-Rodelo; Juan-Manuel Arias; Jesús-Alberto Olivares-Reyes; Richard M van Rijn; José-Antonio Arias-Montaño
Journal:  Pharmacol Res       Date:  2017-12-05       Impact factor: 7.658

8.  Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease.

Authors:  Ranjana Patnaik; Aruna Sharma; Stephen D Skaper; Dafin F Muresanu; José Vicente Lafuente; Rudy J Castellani; Ala Nozari; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Pitolisant in an Adolescent with Prader-Willi Syndrome.

Authors:  Stephanie Pennington; Danielle Stutzman; Elise Sannar
Journal:  J Pediatr Pharmacol Ther       Date:  2021-05-19

Review 10.  Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.

Authors:  B Jupp; J W Dalley
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.